IPcom GmbH & Co Kg v HTC Europe Co Ltd & Ors [2013] EWCA Civ 1496 (21 November 2013)
The Court of Appeal held that the Glaxo guidance on stays requires revision in light of the Supreme Court's decision in Virgin. The default position is that a stay should be granted where there are concurrent EPO opposition proceedings, unless the party resisting the stay can show why it should not be granted. The discretion remains wide, and the balance of justice must be assessed in each case, considering factors such as delay, prejudice, commercial certainty, risk of inconsistent decisions, and wasted costs. The revised guidance was set out in detail in the judgment.
- Citation
- [2013] EWCA Civ 1496
- Parties
- Claimant/respondent: IPCOM GMBH & CO KG; Defendant/appellant: HTC EUROPE CO LIMITED; Defendant/appellant: BRIGHTPOINT GREAT BRITAIN LIMITED; Defendant/appellant: HTC CORPORATION
- Jurisdiction
- England and Wales
- Judgment Date
- 21 November 2013
- Procedural Posture
- Patent Infringement and Revocation Proceedings / Appeal From High Court (patents Court) to Court of Appeal
- Outcome
- Appeal dismissed
- Legal Topics
- Stay of Proceedings, Patent Infringement, Patent Revocation, Concurrent EPO Opposition, Discretion to Stay, FRAND Licensing, Case Management
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
IPCOM GMBH & CO KG
Claimant/respondent
HTC EUROPE CO LIMITED
Defendant/appellant
BRIGHTPOINT GREAT BRITAIN LIMITED
Defendant/appellant
HTC CORPORATION
Defendant/appellant
Procedural Posture
Patent Infringement and Revocation Proceedings / Appeal From High Court (patents Court) to Court of Appeal
Legal Issues
- 1 Whether the Patents Court should grant a stay of national proceedings pending the outcome of EPO opposition proceedings
- 2 Whether the Glaxo guidance on stays requires revision in light of the Supreme Court's decision in Virgin Atlantic Airways Ltd v Zodiac Seats UK Ltd
Ratio Decidendi
The Court of Appeal held that the Glaxo guidance on stays requires revision in light of the Supreme Court's decision in Virgin. The default position is that a stay should be granted where there are concurrent EPO opposition proceedings, unless the party resisting the stay can show why it should not be granted. The discretion remains wide, and the balance of justice must be assessed in each case, considering factors such as delay, prejudice, commercial certainty, risk of inconsistent decisions, and wasted costs. The revised guidance was set out in detail in the judgment.
Court Disposition
Appeal dismissed
Orders
- The order of Roth J refusing a stay is upheld.
- The technical trial in the HTC action will proceed as scheduled.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment